Integrated Analysis of the m6A-Related lncRNA Identified lncRNA ABALON/miR-139-3p/NOB1 Axis Was Involved in the Occurrence of Lung Cancer

References

• Chen R, Xu X, Qian Z, et al. The biological functions and clinical applications of exosomes in lung cancer. Cell Mol Life Sci. 2109;76(23):4613–4633. doi:10.1007/s00018-019-03233-y
   PubMed Web of Science ®Google Scholar
• Quintanal-Villalonga Á, Molina-Pinelo S. Epigenetics of lung cancer: a translational perspective. Cell Oncol. 2019;42(6):739–756. doi:10.1007/s13402-019-00465-9
   Web of Science ®Google Scholar
• Han W, Ren X, Yang Y, et al. microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1. Thorac Cancer. 2020;11(6):1679–1688. doi:10.1111/1759-7714.1345932364673
   PubMed Web of Science ®Google Scholar
• Reck M, Heigener DF, Mok T, et al. Management of non-small-cell lung cancer: recent developments. Lancet. 2013;382(9893):709–719. doi:10.1016/S0140-6736(13)61502-023972814
   PubMed Web of Science ®Google Scholar
• Forde PM, Brahmer JR, Kelly RJ. New strategies in lung cancer: epigenetic therapy for non-small cell lung cancer. Clin Cancer Res. 2014;20(9):2244–2248. doi:10.1158/1078-0432.CCR-13-208824644000
   PubMed Web of Science ®Google Scholar
• Paraskevopoulou MD, Hatzigeorgiou AG. Analyzing miRNA-lncRNA interactions. Methods Mol Biol. 2106;1402:271–286. doi:10.1007/978-1-4939-3378-5_21
   PubMedGoogle Scholar
• Huang Y. The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases. J Cell Mol Med. 2018;22(12):5768–5775. doi:10.1111/jcmm.1386630188595
   PubMed Web of Science ®Google Scholar
• Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350–355. doi:10.1038/nature0287115372042
   PubMed Web of Science ®Google Scholar
• Tutar Y. miRNA and cancer; computational and experimental approaches. Curr Pharm Biotechnol. 2014;15(5):429. doi:10.2174/13892010150514082816133525189575
   PubMed Web of Science ®Google Scholar
• Zhao Y, Feng C, Li Y, et al. LncRNA H19 promotes lung cancer proliferation and metastasis by inhibiting miR-200a function. Mol Cell Biochem. 2019;460(1–2):1–8. doi:10.1007/s11010-019-03564-131187349
   PubMed Web of Science ®Google Scholar
• Xu Y, Lin J, Jin Y, et al. The miRNA hsa-miR-6515-3p potentially contributes to lncRNA H19-mediated-lung cancer metastasis. J Cell Biochem. 2019;120(10):17413–17421. doi:10.1002/jcb.2900631131469
   PubMed Web of Science ®Google Scholar
• Wang M, Mao C, Ouyang L, et al. Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA. Cell Death Differ. 2019;26(11):2329–2343. doi:10.1038/s41418-019-0304-y30787392
   PubMed Web of Science ®Google Scholar
• Pan J, Fang S, Tian H, et al. lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling. Mol Cancer. 2020;19(1):9. doi:10.1186/s12943-020-1133-931941509
   PubMed Web of Science ®Google Scholar
• Zhen Q, Gao LN, Wang RF, et al. LncRNA DANCR promotes lung cancer by sequestering miR-216a. Cancer Control. 2018;25(1):107327481876984. doi:10.1177/1073274818769849
   Web of Science ®Google Scholar
• Zhao BS, Roundtree IA, He C. Post-transcriptional gene regulation by mRNA modifications. Nat Rev Mol Cell Biol. 2017;18(1):31–42. doi:10.1038/nrm.2016.13227808276
   PubMed Web of Science ®Google Scholar
• Dai D, Wang H, Zhu L, et al. N6-methyladenosine links RNA metabolism to cancer progression. Cell Death Dis. 2018;9(2):124. doi:10.1038/s41419-017-0129-x29374143
   PubMed Web of Science ®Google Scholar
• Yang X, Shao F, Guo D, et al. WNT/β-catenin-suppressed FTO expression increases m6A of c-Myc mRNA to promote tumor cell glycolysis and tumorigenesis. Cell Death Dis. 2021;12(5):462. doi:10.1038/s41419-021-03739-z33966037
   PubMed Web of Science ®Google Scholar
• Shi Y, Fan S, Wu M, et al. YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression. Nat Commun. 2019;10(1):4892. doi:10.1038/s41467-019-12801-631653849
   PubMed Web of Science ®Google Scholar
• Lou X, Ning J, Liu W, et al. YTHDF1 promotes cyclin B1 translation through m6A modulation and contributes to the poor prognosis of lung adenocarcinoma with KRAS/TP53 co-mutation. Cells. 2021;10(7):1669. doi:10.3390/cells1007166934359836
   PubMed Web of Science ®Google Scholar
• Chen Y, Lin Y, Shu Y, et al. Interaction between N6-methyladenosine (m6A) modification and noncoding RNAs in cancer. Mol Cancer. 2020;19(1):94. doi:10.1186/s12943-020-01207-432443966
   PubMed Web of Science ®Google Scholar
• Ma JZ, Yang F, Zhou CC, et al. METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N6 -methyladenosine-dependent primary microRNA processing. Hepatology. 2017;65(2):529–543. doi:10.1002/hep.2888527774652
   PubMed Web of Science ®Google Scholar
• Meyer KD, Jaffrey SR. Rethinking m6A readers, writers, and erasers. Annu Rev Cell Dev Biol. 2017;33:319–342. doi:10.1146/annurev-cellbio-100616-06075828759256
   PubMed Web of Science ®Google Scholar
• Zaccara S, Ries RJ, Jaffrey SR. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol. 2019;20(10):608–624. doi:10.1038/s41580-019-0168-531520073
   PubMed Web of Science ®Google Scholar
• Shi H, Wei J, He C. Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers. Mol Cell. 2019;74(4):640–650. doi:10.1016/j.molcel.2019.04.02531100245
   PubMed Web of Science ®Google Scholar
• Deng S, Zhang H, Zhu K, et al. M6A2Target: a comprehensive database for targets of m6A writers, erasers and readers. Brief Bioinform. 2021;22(3):bbaa055. doi:10.1093/bib/bbaa05532392583
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.2133826808342
   PubMed Web of Science ®Google Scholar
• Yang Y, Ding L, Hu Q, et al. MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis. Mol Cancer. 2017;16(1):141. doi:10.1186/s12943-017-0710-z28830450
   PubMed Web of Science ®Google Scholar
• Travis WD. Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas. Mod Pathol. 2012;25:S18–S30. doi:10.1038/modpathol.2011.15022214967
   PubMed Web of Science ®Google Scholar
• Mao Y, Xue P, Li L, et al. Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA-gene pairs in small-cell lung cancer. Mol Med Rep. 2019;20(3):2199–2208. doi:10.3892/mmr.2019.1044131257520
   PubMed Web of Science ®Google Scholar
• Cao Z, Pan X, Yang Y, et al. The lncLocator: a subcellular localization predictor for long non-coding RNAs based on a stacked ensemble classifier. Bioinformatics. 2018;34(13):2185–2194. doi:10.1093/bioinformatics/bty08529462250
   PubMed Web of Science ®Google Scholar
• Huang P, Xi J, Liu S. MiR-139-3p induces cell apoptosis and inhibits metastasis of cervical cancer by targeting NOB1. Biomed Pharmacother. 2016;83:850–856. doi:10.1016/j.biopha.2016.07.05027505862
   PubMed Web of Science ®Google Scholar
• Zou ZC, Dai M, Huang ZY, et al. MicroRNA-139-3p suppresses tumor growth and metastasis in hepatocellular carcinoma by repressing ANXA2R. Oncol Res. 2018;26(9):1391–1399. doi:10.3727/096504018X1517879888536129422116
   PubMed Web of Science ®Google Scholar
• Shi L, Yuan Y, Li HY. MicroRNA-139-3p suppresses growth and metastasis of glioblastoma via inhibition of NIN1/RPNI2 binding protein 1 homolog. Eur Rev Med Pharmacol Sci. 2019;23(10):4264–4274. doi:10.26355/eurrev_201905_1793131173298
   PubMed Web of Science ®Google Scholar
• Xue F, Li QR, Xu YH, et al. MicroRNA-139-3p inhibits the growth and metastasis of ovarian cancer by inhibiting ELAVL1. Oncol Rep. 2019;12:8935–8945. doi:10.2147/OTT.S210739
   Web of Science ®Google Scholar
• Zhang W, Xu J, Wang K, et al. miR-139-3p suppresses the invasion and migration properties of breast cancer cells by targeting RAB1A. Oncol Rep. 2019;42(5):1699–1708. doi:10.3892/or.2019.729731485677
   PubMed Web of Science ®Google Scholar
• Ma Y, Chen Z, Yu G. microRNA-139-3p inhibits malignant behaviors of laryngeal cancer cells via the KDM5B/SOX2 axis and the Wnt/β-Catenin pathway. Cancer Manag Res. 2020;12:9197–9209. doi:10.2147/CMAR.S26887133061611
   PubMed Web of Science ®Google Scholar
• Ni ZZ, He JK, Tang X, et al. Identification of ELAVL1 gene and miRNA-139-3p involved in the aggressiveness of NSCLC. Eur Rev Med Pharmacol Sci. 2020;24(18):9453–9464. doi:10.26355/eurrev_202009_2303033015787
   PubMed Web of Science ®Google Scholar
• Zhu Y, Zhou C, He Q. High miR-139-3p expression predicts a better prognosis for hepatocellular carcinoma: a pooled analysis. J Int Med Res. 2019;47(1):383–390. doi:10.1177/030006051880272730394818
   PubMed Web of Science ®Google Scholar
• Li Y, Ma C, Qian M, et al. Downregulation of NOB1 suppresses the proliferation and tumor growth of non-small cell lung cancer in vitro and in vivo. Oncol Rep. 2020;43(3):1031. doi:10.3892/or.2020.748332020218
   PubMed Web of Science ®Google Scholar
• Liu K, Chen HL, Gu MM, et al. NOB1 expression predicts early response to cisplatin-based chemotherapy in patients with advanced non-small cell lung cancer. J Chemother. 2016;28(3):225–229. doi:10.1179/1973947815Y.000000004125971309
   PubMed Web of Science ®Google Scholar